This article is the third in an occasional series, which highlights issues that have arisen in some significant patent law cases concerning bioethics. Here we look at the Myriad case which, as well as raising questions about patenting genetic inventions, demonstrates how certain bioethical issues go beyond questions of patentability, to the way in which a patent, once granted, is exercised in the marketplace.
展开▼
